Logo image
Back
Sacrocolpopexy experience with a novel robotic surgical platform
Journal article   Peer reviewed

Sacrocolpopexy experience with a novel robotic surgical platform

Jessica C. Sassani, Stephanie Glass Clark, Christine E. McGough, Jonathan P. Shepherd and Michael Bonidie
International Urogynecology Journal, v 33(11), pp 3255-3260
01 Nov 2022
DOI: https://doi.org/10.1007/s00192-022-05155-z
PMID: 35312804
Featured in Collection :   UN Sustainable Development Goals @ Drexel

Abstract

Gynecology Medicine Medicine & Public Health Original Article Urology
Introduction and hypothesis The objective was to describe early experience performing sacrocolpopexy using a novel robotic surgical platform. Methods This is a case series of all women who underwent robotic-assisted sacrocolpopexy using a new robotics platform (TransEnterix Senhance) between January 2019 and July 2021. All sacrocolpopexies were performed by a single Female Pelvic Medicine and Reconstructive surgeon at a large academic institution. Perioperative information including complications was abstracted from the medical record. Anatomical recurrence was defined as any anatomical point at or past the hymen (≥0). Data are descriptive, with Mann–Whitney U test used for comparison of operative time between the first and second half of the patients. Results A total of 25 sacrocolpopexies were performed using the new robotics platform. Mean age was 62.3 years (±9.2) and mean BMI was 26.5 (±3.8). Ten (40.0%) patients had a prior hysterectomy. Most ( n = 21, 84.0%) had stage III or IV prolapse preoperatively. Mean operative time was 210.2 min (±48.6) and median estimated blood loss was 35 ml (IQR 25–50). Mean operative time decreased between the first and second half of the patients (231.7 min vs 190.3 min, p = 0.047). There were no major intraoperative complications. Median follow-up time was 16 weeks (IQR 4–34) and there were no subjective recurrences or retreatments during this period. Two patients (8.0%) had anatomical recurrence without subjective bother. There were two postoperative readmissions (8.0%) within 30 days for small bowel obstruction, one treated surgically and the other with nonsurgical management. Conclusions Our case series demonstrates feasibility and successful early adoption of a new robotics platform for robotic sacrocolpopexy.

Metrics

6 Record Views
9 citations in Web of Science

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Obstetrics & Gynecology
Urology & Nephrology
Logo image